Related Experiment Video
Updated: Feb 13, 2026

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
Published on: June 28, 2021
Apoptin, A Versatile Protein with Selective Antitumor Activity
Jessica Castro1, Marc Ribo1, Antoni Benito1
1Laboratori d`Enginyeria de Proteines, Departament de Biologia, Facultat de Ciencies, Universitat de Girona, Campus de Montilivi, Maria Aurelia Capmany 40, 17003, Girona, Spain.
Background:
Research in the field of antitumor chemotherapeutics pursues a key issue, drug selectivity for cancer cells. In the last 20 years, a group of proteins has attracted scientific interest as cancer chemotherapeutics due to their ability to specifically kill cancer cells while leaving normal cells undamaged. One of these proteins is apoptin.
Methods:
In this study, the recent available literature regarding cell death mechanisms induced by apoptin has been reviewed. Delivering this drug to tumor cells is a challenge because it spontaneously forms soluble non-covalent aggregates. This led us to include in this review the different approaches for obtaining the maximum efficiency of apoptin entry to cancer cells.
Results:
This review provides an up-to-date summary of the mechanisms by which apoptin induces selective apoptosis in tumor cells while leaving normal cells undamaged. It highlights the relationship between the apoptosis mechanism induced by this protein and its functional motifs. Apoptin has been described as an intrinsically disordered protein, which explains its ability to interact with multiple partners and affect multiple pathways inside the cell. Characterization of the different partners and pathways induced by apoptin has begun to shed light on the molecular basis of apoptin's tumor-selective cytotoxicity.
Conclusion:
The findings confirm the interest in apoptin as a potentially safe antitumor drug. Research still needed to be conducted to find an effective way to deliver apoptin for use in clinics.
Insights
Apoptin selectively kills cancer cells by inducing apoptosis, offering a promising avenue for antitumor chemotherapy. Further research is needed to optimize its delivery for clinical use.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Drug selectivity for cancer cells is a critical challenge in antitumor chemotherapy.
- Apoptin, a protein, has emerged as a potential chemotherapeutic agent due to its ability to selectively eliminate cancer cells.
- This protein has garnered significant scientific interest for its tumor-specific cytotoxic effects.
Purpose of the Study:
- To review the cell death mechanisms induced by apoptin.
- To explore strategies for enhancing apoptin's delivery to tumor cells.
- To summarize the molecular basis of apoptin's tumor-selective cytotoxicity.
Main Methods:
- Literature review of apoptin's cell death mechanisms.
- Analysis of challenges in delivering apoptin to tumor cells due to aggregate formation.
- Examination of approaches to improve apoptin's efficiency in cancer cells.
Main Results:
- Apoptin induces selective apoptosis in tumor cells, sparing normal cells.
- The protein's intrinsically disordered nature facilitates interactions with multiple cellular partners and pathways.
- Functional motifs of apoptin are linked to its apoptosis-inducing mechanisms and tumor selectivity.
Conclusions:
- Apoptin shows significant potential as a safe antitumor therapeutic agent.
- Effective delivery methods for apoptin are crucial for its clinical application.
- Continued research is necessary to overcome delivery challenges and translate apoptin into clinical practice.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Activation and Inactivation of G Proteins
What is Natural Selection?
Antibiotic Selection
Types of Selection
Frequency-dependent Selection

